478 related articles for article (PubMed ID: 19374532)
1. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor.
Dufaÿ Wojcicki A; Hillaireau H; Nascimento TL; Arpicco S; Taverna M; Ribes S; Bourge M; Nicolas V; Bochot A; Vauthier C; Tsapis N; Fattal E
J Control Release; 2012 Sep; 162(3):545-52. PubMed ID: 22820451
[TBL] [Abstract][Full Text] [Related]
3. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.
Surace C; Arpicco S; Dufaÿ-Wojcicki A; Marsaud V; Bouclier C; Clay D; Cattel L; Renoir JM; Fattal E
Mol Pharm; 2009; 6(4):1062-73. PubMed ID: 19413341
[TBL] [Abstract][Full Text] [Related]
4. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
5. Supramolecular Organization and siRNA Binding of Hyaluronic Acid-Coated Lipoplexes for Targeted Delivery to the CD44 Receptor.
Nascimento TL; Hillaireau H; Noiray M; Bourgaux C; Arpicco S; Pehau-Arnaudet G; Taverna M; Cosco D; Tsapis N; Fattal E
Langmuir; 2015 Oct; 31(41):11186-94. PubMed ID: 26375384
[TBL] [Abstract][Full Text] [Related]
6. The synergy between structural stability and DNA-binding controls the antibody production in EPC/DOTAP/DOPE liposomes and DOTAP/DOPE lipoplexes.
de la Torre LG; Rosada RS; Trombone AP; Frantz FG; Coelho-Castelo AA; Silva CL; Santana MH
Colloids Surf B Biointerfaces; 2009 Oct; 73(2):175-84. PubMed ID: 19540734
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy.
Martens TF; Peynshaert K; Nascimento TL; Fattal E; Karlstetter M; Langmann T; Picaud S; Demeester J; De Smedt SC; Remaut K; Braeckmans K
Eur J Pharm Sci; 2017 May; 103():27-35. PubMed ID: 28223236
[TBL] [Abstract][Full Text] [Related]
8. DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery.
Li H; Hao Y; Wang N; Wang L; Jia S; Wang Y; Yang L; Zhang Y; Zhang Z
Drug Deliv; 2016; 23(3):840-8. PubMed ID: 24892622
[TBL] [Abstract][Full Text] [Related]
9. DOTAP/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes.
Kim BK; Hwang GB; Seu YB; Choi JS; Jin KS; Doh KO
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):1996-2001. PubMed ID: 26112463
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model.
Leite Nascimento T; Hillaireau H; Vergnaud J; Rivano M; Deloménie C; Courilleau D; Arpicco S; Suk JS; Hanes J; Fattal E
Int J Pharm; 2016 Nov; 514(1):103-111. PubMed ID: 27863652
[TBL] [Abstract][Full Text] [Related]
11. Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA.
Beisner J; Dong M; Taetz S; Piotrowska K; Kleideiter E; Friedel G; Schaefer U; Lehr CM; Klotz U; Mürdter TE
J Pharm Sci; 2009 May; 98(5):1765-74. PubMed ID: 18803262
[TBL] [Abstract][Full Text] [Related]
12. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
13. Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes.
Remaut K; Sanders NN; Fayazpour F; Demeester J; De Smedt SC
J Control Release; 2006 Oct; 115(3):335-43. PubMed ID: 17010468
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting DNA binding and stability of association to cationic liposomes.
Even-Chen S; Cohen R; Barenholz Y
Chem Phys Lipids; 2012 May; 165(4):414-23. PubMed ID: 22715503
[TBL] [Abstract][Full Text] [Related]
15. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
Wang J; Ayano E; Maitani Y; Kanazawa H
Int J Pharm; 2017 May; 523(1):217-228. PubMed ID: 28330734
[TBL] [Abstract][Full Text] [Related]
17. Enhanced transfection efficiency and reduced cytotoxicity of novel lipid-polymer hybrid nanoplexes.
Jain S; Kumar S; Agrawal AK; Thanki K; Banerjee UC
Mol Pharm; 2013 Jun; 10(6):2416-25. PubMed ID: 23597269
[TBL] [Abstract][Full Text] [Related]
18. Effect of "helper lipid" on lipoplex electrostatics.
Hirsch-Lerner D; Zhang M; Eliyahu H; Ferrari ME; Wheeler CJ; Barenholz Y
Biochim Biophys Acta; 2005 Aug; 1714(2):71-84. PubMed ID: 16051183
[TBL] [Abstract][Full Text] [Related]
19. Lipoplexes from Non-viral Cationic Vectors: DOTAP-DOPE Liposomes and Gemini Micelles.
Falsini S; Ristori S
Methods Mol Biol; 2016; 1445():33-43. PubMed ID: 27436311
[TBL] [Abstract][Full Text] [Related]
20. Liposomal siRNA delivery.
Hughes J; Yadava P; Mesaros R
Methods Mol Biol; 2010; 605():445-59. PubMed ID: 20072900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]